Physician profile

Jennifer B Marks

Endocrinology, Diabetes & Metabolism · Miami, FL

NPI 1306802780

$1,880.00

in general payments reported to CMS, 2019-2025

2 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $1,880.00 2019

1 company reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jennifer B Marks

$1,880.00

in general payments reported 2019-2025

Years
2019
Top company
Novo Nordisk INC

https://glasscript.com/doctor/331545/jennifer-b-marks

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.